Home » Topics » Regulatory » Patents

Patents
RSS

Novel antiinfective agents disclosed in recent patent literature

Nov. 30, 2006

New PDE4/TNF-alpha inhibitors emerge from Nippon Shinyaku R&D

Nov. 30, 2006

Recent patents disclose novel agents with potential in the treatment of HCV infection

Nov. 29, 2006

Novel Rho kinase inhibitors revealed in D. Western Therapeutics patents

Nov. 29, 2006

Sankyo patents novel compounds for transplant rejection, autoimmune diseases, etc.

Nov. 29, 2006

New antiarthritic compounds discovered according to recent patents

Nov. 28, 2006

Novel PDE4 inhibitors patented by Boehringer Ingelheim, Ranbaxy

Nov. 28, 2006

Recent patent literature reports new therapeutic agents insomnia, anxiety, etc.

Nov. 28, 2006

New anticancer agents imparted in recent patents

Nov. 28, 2006

Novel agents with potential use in the treatment of obesity and lipoprotein disorders described

Nov. 27, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...